
Chinese-owned Swiss agritech group explores a blockbuster listing in Hong Kong that could become one of the year’s largest offerings as it retools growth plans
Syngenta Group is preparing to return to public markets with a potential initial public offering in Hong Kong that could raise as much as US$10 billion, marking one of the largest expected listings in the city this year.
The agribusiness and crop protection specialist is in preliminary talks with global and regional banks about arranging the offering, with discussions at an early stage and final terms yet to be determined.
The Basel-based company, owned by Chinese state-owned Sinochem Group, could sell up to 20 per cent of its shares as part of the float.
No official timetable or final decision on the size of the deal has been announced, and Syngenta said it does not comment on market rumours.
However, it stated that it will evaluate capital markets strategies based on prevailing conditions and in the interests of its shareholders.
The Hong Kong listing plan follows Syngenta’s decision in 2024 to abandon a proposed IPO on the Shanghai Stock Exchange amid challenging market conditions and tighter regulatory scrutiny.
The renewed push reflects improved sentiment in Hong Kong’s equity markets, which have regained momentum and ranked among the world’s busiest venues for initial public offerings.
Sources with knowledge of the discussions said Syngenta is in talks with banks including Goldman Sachs, UBS, Morgan Stanley, HSBC and China’s CICC for potential roles in the deal.
Part of the proceeds from the offering may be used to reduce existing debt, while additional funds could support research and development, acquisitions and broader growth initiatives.
Net debt stood at nearly US$25 billion as of the end of 2024.
Analysts say a successful float could position Syngenta to compete more effectively with global rivals in seeds and crop protection and bolster its investment capacity in technologies such as digital agriculture and artificial intelligence tools for farming.
With Hong Kong’s fundraising environment strengthening in recent months, the potential listing — if completed by the end of 2026 as anticipated — would underscore the city’s appeal as a leading IPO centre in Asia.
The agribusiness and crop protection specialist is in preliminary talks with global and regional banks about arranging the offering, with discussions at an early stage and final terms yet to be determined.
The Basel-based company, owned by Chinese state-owned Sinochem Group, could sell up to 20 per cent of its shares as part of the float.
No official timetable or final decision on the size of the deal has been announced, and Syngenta said it does not comment on market rumours.
However, it stated that it will evaluate capital markets strategies based on prevailing conditions and in the interests of its shareholders.
The Hong Kong listing plan follows Syngenta’s decision in 2024 to abandon a proposed IPO on the Shanghai Stock Exchange amid challenging market conditions and tighter regulatory scrutiny.
The renewed push reflects improved sentiment in Hong Kong’s equity markets, which have regained momentum and ranked among the world’s busiest venues for initial public offerings.
Sources with knowledge of the discussions said Syngenta is in talks with banks including Goldman Sachs, UBS, Morgan Stanley, HSBC and China’s CICC for potential roles in the deal.
Part of the proceeds from the offering may be used to reduce existing debt, while additional funds could support research and development, acquisitions and broader growth initiatives.
Net debt stood at nearly US$25 billion as of the end of 2024.
Analysts say a successful float could position Syngenta to compete more effectively with global rivals in seeds and crop protection and bolster its investment capacity in technologies such as digital agriculture and artificial intelligence tools for farming.
With Hong Kong’s fundraising environment strengthening in recent months, the potential listing — if completed by the end of 2026 as anticipated — would underscore the city’s appeal as a leading IPO centre in Asia.










































